Drug Shortage Report for AERRANE
| Report ID | 177708 |
| Drug Identification Number | 02225875 |
| Brand name | AERRANE |
| Common or Proper name | ISOFLURANE |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | ISOFLURANE |
| Strength(s) | 100% |
| Dosage form(s) | LIQUID |
| Route of administration | INHALATION INHALATION |
| Packaging size | 250mL Bottle |
| ATC code | |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-12-09 |
| Actual start date | 2022-12-09 |
| Estimated end date | 2023-01-16 |
| Actual end date | 2023-01-16 |
| Shortage status | Resolved |
| Updated date | 2023-01-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-01-17 | English | Compare |
| v5 | 2023-01-16 | French | Compare |
| v4 | 2023-01-16 | English | Compare |
| v3 | 2022-12-10 | English | Compare |
| v2 | 2022-12-09 | French | Compare |
| v1 | 2022-12-09 | English | Compare |
Showing 1 to 6 of 6